Close Menu

Amgen

Decode's Q4 revenues rose 21 percent, but the firm said that it only has enough liquid assets to fund operations into the second quarter of this year.

Some in the clinical genetics community believe the rise of DTC testing offers a prime opportunity to raise awareness of genetics among the general population, despite skepticism about using the tests for clinical decision-making.

New Releases: Mar 25, 2009

Premium

DxS' TheraScreen KRAS Mutation Kit

Jerry Hill, Chad Ziegler, Michael Allen Luther, Drew Harris, Christopher Donovan

DxS get EU approval to sell its TheraScreen K-RAS Mutation Kit for use on Roche's LightCycler instrument and licensed rights to related software.

Updating the HHS Secretary's Advisory Committee on Genetics, Health, and Society regarding New York’s regulatory stance on consumer genomics firms, a health department official said companies that obtain raw data from an analytical testing facility and send a report to an ordering practitioner are considered laboratories.

In opening its new translational research lab, Mass General claims to be "the first and only cancer center" to attempt to molecularly profile all cancer patients that present to the facility.

Seahorse acquired the maker of the SimCell System, a fully integrated cell culture automation system used for selecting clones, optimizing media, and determining the best process conditions for protein manufacturing, for an undisclosed sum. It also raised $6 million in funding from VC investors.

The FDA has confirmed to DxS that its TheraScreen KRAS test is a Class III device. The company is in the process of submitting its premarket approval application to the agency.

Imperial College London and its spinout DNA Electronics have created a prototype for the so-called SNP Dr., which is being developed under a £1.2 million project that also includes Pfizer.

Pages

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.